- Home
- NWBI vs GLPG Comparison
NWBI vs GLPG Comparison
Compare NWBI & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWBI
- GLPG
- Stock Information
- Founded
- NWBI 1896
- GLPG 1999
- Country
- NWBI United States
- GLPG Belgium
- Employees
- NWBI N/A
- GLPG N/A
- Industry
- NWBI Major Banks
- GLPG Biotechnology: Pharmaceutical Preparations
- Sector
- NWBI Finance
- GLPG Health Care
- Exchange
- NWBI Nasdaq
- GLPG Nasdaq
- Market Cap
- NWBI 1.8B
- GLPG 2.1B
- IPO Year
- NWBI N/A
- GLPG 2005
- Fundamental
- Price
- NWBI $12.17
- GLPG $34.74
- Analyst Decision
- NWBI Buy
- GLPG Sell
- Analyst Count
- NWBI 2
- GLPG 3
- Target Price
- NWBI $15.00
- GLPG $26.00
- AVG Volume (30 Days)
- NWBI 861.7K
- GLPG 224.9K
- Earning Date
- NWBI 10-27-2025
- GLPG 11-05-2025
- Dividend Yield
- NWBI 6.41%
- GLPG N/A
- EPS Growth
- NWBI 39.35
- GLPG N/A
- EPS
- NWBI 1.12
- GLPG N/A
- Revenue
- NWBI $561,855,000.00
- GLPG $323,674,692.00
- Revenue This Year
- NWBI $6.98
- GLPG $1.77
- Revenue Next Year
- NWBI $11.67
- GLPG $0.44
- P/E Ratio
- NWBI $11.14
- GLPG N/A
- Revenue Growth
- NWBI 14.22
- GLPG 5.43
- 52 Week Low
- NWBI $10.75
- GLPG $22.36
- 52 Week High
- NWBI $15.42
- GLPG $37.78
- Technical
- Relative Strength Index (RSI)
- NWBI 46.47
- GLPG 54.80
- Support Level
- NWBI $12.05
- GLPG $33.13
- Resistance Level
- NWBI $12.74
- GLPG $34.80
- Average True Range (ATR)
- NWBI 0.26
- GLPG 0.77
- MACD
- NWBI -0.00
- GLPG -0.17
- Stochastic Oscillator
- NWBI 34.67
- GLPG 32.26
About NWBI Northwest Bancshares Inc.
Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution offering personal and commercial banking business solutions, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and business banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Business banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.